1. Home
  2. SPHL vs CELZ Comparison

SPHL vs CELZ Comparison

Compare SPHL & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SPHL

Springview Holdings Ltd Class A Ordinary Shares

HOLD

Current Price

$2.74

Market Cap

5.9M

ML Signal

HOLD

Logo Creative Medical Technology Holdings Inc.

CELZ

Creative Medical Technology Holdings Inc.

N/A

Current Price

$1.23

Market Cap

5.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SPHL
CELZ
Founded
2002
1998
Country
Singapore
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
5.1M
IPO Year
2023
2008

Fundamental Metrics

Financial Performance
Metric
SPHL
CELZ
Price
$2.74
$1.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.3K
11.2M
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.08
EPS
N/A
N/A
Revenue
N/A
$6,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$0.62
52 Week High
$25.11
$6.25

Technical Indicators

Market Signals
Indicator
SPHL
CELZ
Relative Strength Index (RSI) 47.60 56.72
Support Level $2.48 $0.74
Resistance Level $2.74 $2.42
Average True Range (ATR) 0.17 0.19
MACD 0.02 0.08
Stochastic Oscillator 24.29 46.21

Price Performance

Historical Comparison
SPHL
CELZ

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd conducts its operations through its indirect wholly-owned subsidiary, which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of work, including new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment in the development of construction projects. It derives maximum revenue from its Residential Customers.

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.

Share on Social Networks: